Skip to Content
MilliporeSigma
All Photos(1)

Documents

1598405

USP

Ranitidine hydrochloride

United States Pharmacopeia (USP) Reference Standard

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C13H22N4O3S · HCl
CAS Number:
66357-59-3
Molecular Weight:
350.86
MDL number:
MFCD00069339
UNSPSC Code:
41116107
PubChem Substance ID:
329751022
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

ranitidine

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

Cl[H].CN\C(NCCSCc1ccc(CN(C)C)o1)=C\[N+]([O-])=O

InChI

1S/C13H22N4O3S.ClH/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;/h4-5,9,14-15H,6-8,10H2,1-3H3;1H/b13-9-;

InChI key

GGWBHVILAJZWKJ-CHHCPSLASA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Ranitidine hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
Also, for use with USP monographs such as:
  • Ranitidine Injection
  • Ranitidine Tablets
  • Ranitidine in Sodium Chloride Injection
  • Ranitidine Oral Solution

Biochem/physiol Actions

H2 histamine receptor antagonist; anti-ulcer agent.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

related product

Product No.
Description
Pricing

1598507

Ranitidine Related Compound A, United States Pharmacopeia (USP) Reference Standard

1598700

Ranitidine Related Compound C, United States Pharmacopeia (USP) Reference Standard

1598609

Ranitidine Related Compound B, United States Pharmacopeia (USP) Reference Standard

1598450

Ranitidine Resolution Mixture, United States Pharmacopeia (USP) Reference Standard

Y0000416

Ranitidine impurity J, European Pharmacopoeia (EP) Reference Standard

R0150000

Ranitidine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Y0001787

Ranitidine for impurity A identification, European Pharmacopoeia (EP) Reference Standard

PHR1774

Ranitidine Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1773

Ranitidine Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1775

Ranitidine Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

BP471

Ranitidine hydrochloride, British Pharmacopoeia (BP) Reference Standard

PHR2180

Ranitidine Impurity I, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2181

Ranitidine Impurity J, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2179

Ranitidine Impurity H, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2182

Ranitidine Impurity K, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2175

Ranitidine Impurity D, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2177

Ranitidine Impurity F

PHR2178

Ranitidine Impurity G, Pharmaceutical Secondary Standard; Certified Reference Material

pictograms

Health hazardExclamation mark
GHS08,GHS07

signalword

Danger

Hazard Classifications

Eye Irrit. 2 - Resp. Sens. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 8

1 of 8

Ranitidine Related Compound B Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1774

Ranitidine Related Compound B

Famotidine

Sigma-Aldrich

F6889

Famotidine

Cimetidine

Sigma-Aldrich

C4522

Cimetidine

Guaifenesin United States Pharmacopeia (USP) Reference Standard

USP

1301007

Guaifenesin

Antipyrine analytical standard

Supelco

A5882

Antipyrine

Famotidine Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1055

Famotidine

Caffeine Melting Point Standard Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1095

Caffeine Melting Point Standard

Caffeine Sigma Reference Standard, vial of 250 mg

Sigma-Aldrich

C1778

Caffeine

Question 1: does the use of ranitidine increase the risk of NEC in preterm infants?
Manigandan Chandrasekaran et al.
Archives of disease in childhood, 99(4), 390-392 (2014-03-15)
T S Gaginella et al.
Drug intelligence & clinical pharmacy, 17(12), 873-885 (1983-12-01)
Ranitidine is a selective, competitive histamine H2-receptor antagonist recently approved by the Food and Drug Administration for use in the short-term treatment of active duodenal ulcers and gastric hypersecretory conditions. Ranitidine is four to ten times more potent than cimetidine
M B Evans et al.
Journal of pharmaceutical and biomedical analysis, 7(1), 1-22 (1989-01-01)
The selection, development, definition and validation of selective stability-indicating procedures for high-performance liquid chromatographic and thin-layer chromatographic analyses of ranitidine hydrochloride are described. The procedures used in conjunction can be applied to the quality assurance and stability assessments of both
[The development of hemorrhagic vasculitis (Schönlein-Henoch disease) in a patient with a chronic stomach ulcer against a background of Sostril (ranitidine hydrochloride) therapy].
E N Glazunov et al.
Vestnik khirurgii imeni I. I. Grekova, 152(1-2), 102-103 (1994-01-01)
Natalia Alonso et al.
The Biochemical journal, 459(1), 117-126 (2014-01-15)
7TMRs (seven-transmembrane receptors) exist as conformational collections in which different conformations would lead to differential downstream behaviours such as receptor phosphorylation, G-protein activation and receptor internalization. In this context, a ligand may cause differential activation of some, but not all
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service